<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li RH</submitter><funding>National Natural Science Foundation of China</funding><funding>NIGMS NIH HHS</funding><funding>National Natural Science Foundation of China (National Science Foundation of China)</funding><pagination>1088-1105</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8486796</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>31(10)</volume><pubmed_abstract>Long noncoding RNAs (lncRNAs) are emerging as a new class of important regulators of signal transduction in tissue homeostasis and cancer development. Liquid-liquid phase separation (LLPS) occurs in a wide range of biological processes, while its role in signal transduction remains largely undeciphered. In this study, we uncovered a lipid-associated lncRNA, small nucleolar RNA host gene 9 (SNHG9) as a tumor-promoting lncRNA driving liquid droplet formation of Large Tumor Suppressor Kinase 1 (LATS1) and inhibiting the Hippo pathway. Mechanistically, SNHG9 and its associated phosphatidic acids (PA) interact with the C-terminal domain of LATS1, promoting LATS1 phase separation and inhibiting LATS1-mediated YAP phosphorylation. Loss of SNHG9 suppresses xenograft breast tumor growth. Clinically</pubmed_abstract><journal>Cell research</journal><pubmed_title>A phosphatidic acid-binding lncRNA SNHG9 facilitates LATS1 liquid-liquid phase separation to promote oncogenic YAP signaling.</pubmed_title><pmcid>PMC8486796</pmcid><funding_grant_id>81672791</funding_grant_id><funding_grant_id>82071567</funding_grant_id><funding_grant_id>81872300</funding_grant_id><funding_grant_id>R01 GM126048</funding_grant_id><pubmed_authors>He XY</pubmed_authors><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Liu YZ</pubmed_authors><pubmed_authors>Yan Q</pubmed_authors><pubmed_authors>Li RH</pubmed_authors><pubmed_authors>Zhou T</pubmed_authors><pubmed_authors>Shao JZ</pubmed_authors><pubmed_authors>Shi CY</pubmed_authors><pubmed_authors>Xiong Y</pubmed_authors><pubmed_authors>Liu FZ</pubmed_authors><pubmed_authors>Yang ZZ</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Lin A</pubmed_authors><pubmed_authors>Zhang Z</pubmed_authors><pubmed_authors>Ju HQ</pubmed_authors><pubmed_authors>Tian T</pubmed_authors><pubmed_authors>Wang LJ</pubmed_authors><pubmed_authors>Wang W</pubmed_authors><pubmed_authors>Ge QW</pubmed_authors><pubmed_authors>Li JH</pubmed_authors><pubmed_authors>Sang LJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>A phosphatidic acid-binding lncRNA SNHG9 facilitates LATS1 liquid-liquid phase separation to promote oncogenic YAP signaling.</name><description>Long noncoding RNAs (lncRNAs) are emerging as a new class of important regulators of signal transduction in tissue homeostasis and cancer development. Liquid-liquid phase separation (LLPS) occurs in a wide range of biological processes, while its role in signal transduction remains largely undeciphered. In this study, we uncovered a lipid-associated lncRNA, small nucleolar RNA host gene 9 (SNHG9) as a tumor-promoting lncRNA driving liquid droplet formation of Large Tumor Suppressor Kinase 1 (LATS1) and inhibiting the Hippo pathway. Mechanistically, SNHG9 and its associated phosphatidic acids (PA) interact with the C-terminal domain of LATS1, promoting LATS1 phase separation and inhibiting LATS1-mediated YAP phosphorylation. Loss of SNHG9 suppresses xenograft breast tumor growth. Clinically</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Oct</publication><modification>2025-04-04T12:04:42.179Z</modification><creation>2025-04-04T12:04:42.179Z</creation></dates><accession>S-EPMC8486796</accession><cross_references><pubmed>34267352</pubmed><doi>10.1038/s41422-021-00530-9</doi></cross_references></HashMap>